News
Zacks.com on MSN4h
SAGE to be Acquired by Supernus Pharmaceuticals in $795 Million DealSUPN inks deal to acquire Sage Therapeutics for up to $795 million, securing rights to depression drug Zurzuvae.
Sage Therapeutics shares gained 0.4% to trade at $9.11 on Tuesday. These analysts made changes to their price targets on Sage ...
Sage Therapeutics (SAGE) witnessed a jump in share price last session on above-average trading volume. The latest trend in ...
Recent health headlines spotlight Surgery Partners rejecting Bain Capital's offer, the U.S. betting on China's drug potential ...
Eli Lilly has confirmed plans for a $1.3 billion takeover bid for Verve Therapeutics, upgrading a collaboration between the ...
Calm returned to Wall Street, and U.S. stocks rallied, while oil prices gave back some of their initial spurts following ...
Calm returned to Wall Street on Monday, and U.S. stocks rose, while oil prices gave back some of their initial spurts ...
Calm returned to Wall Street on Monday, and U.S. stocks rose, while oil prices gave back some of their initial spurts following Israel’s attack on Iranian nuclear and military targets at the end of ...
Inquirer Business on MSN15h
Wall Street recovers from Friday’s shock: stocks rise, oil prices easeCalm returned to Wall Street on Monday, and U.S. stocks rose, while oil prices gave back some of their initial spurts ...
Independent.ie on MSN21h
Markets shrug off latest Middle East escalationCalm returned to Wall Street, and US stocks rose yesterday, while oil prices are giving back some of their initial spurts following Israel’s attack on Iranian nuclear and military targets at the end ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback